AAPL   378.34 (+1.52%)
MSFT   209.80 (+0.74%)
FB   240.14 (-0.30%)
GOOGL   1,498.33 (+0.56%)
NVDA   400.49 (+1.42%)
CGC   16.51 (+0.06%)
BABA   246.44 (+4.20%)
TSLA   1,409.44 (+1.41%)
AMD   53.10 (+0.30%)
T   30.39 (+0.23%)
ACB   12.32 (-0.81%)
F   6.06 (-0.98%)
GILD   76.70 (+0.37%)
DIS   113.15 (-0.42%)
BAC   22.97 (-0.17%)
BA   176.94 (-1.08%)
AAPL   378.34 (+1.52%)
MSFT   209.80 (+0.74%)
FB   240.14 (-0.30%)
GOOGL   1,498.33 (+0.56%)
NVDA   400.49 (+1.42%)
CGC   16.51 (+0.06%)
BABA   246.44 (+4.20%)
TSLA   1,409.44 (+1.41%)
AMD   53.10 (+0.30%)
T   30.39 (+0.23%)
ACB   12.32 (-0.81%)
F   6.06 (-0.98%)
GILD   76.70 (+0.37%)
DIS   113.15 (-0.42%)
BAC   22.97 (-0.17%)
BA   176.94 (-1.08%)
AAPL   378.34 (+1.52%)
MSFT   209.80 (+0.74%)
FB   240.14 (-0.30%)
GOOGL   1,498.33 (+0.56%)
NVDA   400.49 (+1.42%)
CGC   16.51 (+0.06%)
BABA   246.44 (+4.20%)
TSLA   1,409.44 (+1.41%)
AMD   53.10 (+0.30%)
T   30.39 (+0.23%)
ACB   12.32 (-0.81%)
F   6.06 (-0.98%)
GILD   76.70 (+0.37%)
DIS   113.15 (-0.42%)
BAC   22.97 (-0.17%)
BA   176.94 (-1.08%)
AAPL   378.34 (+1.52%)
MSFT   209.80 (+0.74%)
FB   240.14 (-0.30%)
GOOGL   1,498.33 (+0.56%)
NVDA   400.49 (+1.42%)
CGC   16.51 (+0.06%)
BABA   246.44 (+4.20%)
TSLA   1,409.44 (+1.41%)
AMD   53.10 (+0.30%)
T   30.39 (+0.23%)
ACB   12.32 (-0.81%)
F   6.06 (-0.98%)
GILD   76.70 (+0.37%)
DIS   113.15 (-0.42%)
BAC   22.97 (-0.17%)
BA   176.94 (-1.08%)
Log in

Compare Biotech Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 AmgenBiogenCelgeneGilead SciencesIllumina
SymbolNASDAQ:AMGNNASDAQ:BIIBNASDAQ:CELGNASDAQ:GILDNASDAQ:ILMN
Price Information
Current Price$252.86$284.84$108.24$76.24$372.86
52 Week RangeBuyHoldHoldHoldHold
Beat the Market™ Rank
Overall Score2.21.91.72.01.4
Analysis Score2.33.11.02.12.2
Community Score3.03.03.63.32.6
Dividend Score3.30.00.02.50.0
Ownership Score1.01.01.01.01.0
Earnings & Valuation Score1.32.53.11.31.3
Analyst Ratings
Consensus RecommendationBuyHoldHoldHoldBuy
Consensus Price Target$246.08$308.70$105.60$79.65$335.12
% Upside from Price Target-2.68% downside8.38% upside-2.44% downside4.48% upside-10.12% downside
Trade Information
Market Cap$150.74 billion$44.03 billion$77.04 billion$95.86 billion$55.77 billion
Beta0.940.541.410.71
Average Volume2,862,6832,082,5086,772,2168,273,985766,643
Sales & Book Value
Annual Revenue$23.36 billion$14.38 billion$15.28 billion$22.45 billion$3.54 billion
Price / Sales6.373.235.044.2615.47
Cashflow$18.66 per share$40.81 per share$8.88 per share$7.25 per share$8.09 per share
Price / Cash13.556.9812.1910.5246.09
Book Value$16.28 per share$73.93 per share$16.98 per share$17.90 per share$31.38 per share
Price / Book15.533.856.374.2611.88
Profitability
Net Income$7.84 billion$5.89 billion$4.05 billion$5.39 billion$1.00 billion
EPS$14.82$33.57$7.61$6.14$6.57
Trailing P/E Ratio19.828.7914.2219.6058.72
Forward P/E Ratio15.068.829.1411.3347.80
P/E Growth$2.19$0.58$0.51$3.37$5.61
Net Margins32.03%40.76%34.63%21.84%26.48%
Return on Equity (ROE)90.75%49.22%78.15%35.44%21.78%
Return on Assets (ROA)15.44%24.26%18.54%12.84%13.70%
Dividend
Annual Payout$6.40N/AN/A$2.72N/A
Dividend Yield2.53%N/AN/A3.57%N/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout Ratio43.18%N/AN/A44.30%N/A
Years of Consecutive Dividend Growth9 YearsN/AN/A4 YearsN/A
Debt
Debt-to-Equity Ratio3.16%0.39%1.51%1.00%0.29%
Current Ratio1.59%1.73%2.89%3.04%4.10%
Quick Ratio1.28%1.54%2.80%2.92%3.74%
Ownership Information
Institutional Ownership Percentage75.75%87.45%71.66%80.15%89.88%
Insider Ownership Percentage0.36%0.54%0.39%0.13%0.38%
Miscellaneous
Employees23,4007,4008,85211,8007,700
Shares Outstanding588.25 million163.19 million711.71 million1.25 billion147.00 million
Next Earnings Date8/4/2020 (Estimated)7/28/2020 (Estimated)N/A8/4/2020 (Estimated)8/3/2020 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.